Octopamine modulates spermathecal muscle contractions in Locusta migratoria.
Octopamine was identified in the spermathecal tissue of Locusta migratoria using HPLC and immunohistochemical techniques. Octopamine-like immunoreactive unpaired median neurons were identified in the VIIth and VIIIth (terminal) abdominal ganglia and octopamine-like immunoreactive axons were present in the ventral ovipositor nerve (branches from this nerve innervate the spermatheca). Stimulatory actions of octopamine on myogenic and neurogenic contractions were observed. Dose-dependent increases in the frequency of myogenic contractions and the amplitude of neurogenic contractions were elicited by the application of octopamine to the spermathecal muscle. Non-sustained basal tension increases were noted in some preparations, although these were not found to be dose-dependent. SchistoFLRFamide (PDVDHVFLRFamide) inhibited octopamine-induced contractions by a maximum of about 30%. In the presence of 3-isobutyl-1 -methylxanthine, octopamine increased cAMP levels in all regions of the spermathecal. The largest increase in cAMP content was found in the spermathecal sac, followed by the straight duct and coil duct. Phentolamine blocked octopamine-induced increases in cAMP levels and abolished the actions of octopamine on myogenic contractions.
Clark
J
J
Department of Zoology, University of Toronto at Mississauga, Ontario, L5L 1C6, Canada.
Lange
A B
AB
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000818:Animals; D000242:Cyclic AMP / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004594:Electrophysiology; D005260:Female; D017952:Ganglia, Invertebrate / Q000502:physiology; D005836:Genitalia, Female / Q000187:drug effects / Q000502:physiology*; D006110:Grasshoppers / Q000502:physiology*; D007150:Immunohistochemistry; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology*; D018482:Muscle, Skeletal / Q000187:drug effects; D009417:Nerve Tissue / Q000502:physiology; D009479:Neuropeptides / Q000494:pharmacology; D009655:Octopamine / Q000032:analysis / Q000037:antagonists & inhibitors / Q000502:physiology*; D010057:Oviducts / Q000187:drug effects / Q000502:physiology*; D010058:Oviposition / Q000502:physiology; D010646:Phentolamine / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology
D009479:Neuropeptides; D010726:Phosphodiesterase Inhibitors; C059573:SchistoFLRFamide; D009655:Octopamine; D000242:Cyclic AMP; D015056:1-Methyl-3-isobutylxanthine; D010646:Phentolamine